Prelude Therapeutics Inc
PRLDNasdaqCIK 1678660HealthcareFiscal year ends Dec 31
Reports and events: 115 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1007:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-387232 |
| 2026-08-1108:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343475 |
| 2026-08-1108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343469 |
| 2026-06-1016:11 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-265835 |
| 2026-05-1207:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-218173 |
| 2026-05-1207:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-218162 |
| 2026-04-2916:08 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001193125-26-191532 |
| 2026-04-2320:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000463 |
| 2026-04-2216:22 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-046848 |
| 2026-04-2119:04 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164510 |
| 2026-04-2006:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-162620 |
| 2026-04-1507:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-155978 |
| 2026-03-1216:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-104204 |
| 2026-03-1008:24 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-099428 |
| 2026-03-1008:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-099424 |
| 2026-02-0309:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-034564 |
| 2026-01-0907:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-008280 |
| 2025-11-1207:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-275887 |
| 2025-11-1207:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-275871 |
| 2025-11-0408:53 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000929638-25-004115 |
| 2025-10-1707:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-25-241968 |
| 2025-09-1907:41 ET | 8-K | 8.01 Other events | 0001193125-25-208187 |
| 2025-08-1407:23 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108417 |
| 2025-08-1407:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-108413 |
| 2025-06-1317:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-059474 |
| 2025-06-1316:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-25-086170 |
| 2025-05-0616:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064566 |
| 2025-05-0616:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-064531 |
| 2025-04-2907:00 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0000950170-25-059549 |
| 2025-04-2516:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-058776 |
| 2025-03-2816:30 ET | 8-K | 3.01 Delisting notice | 0000950170-25-046839 |
| 2025-03-1007:50 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-035921 |
| 2025-03-1007:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-035917 |
| 2025-02-0516:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-014543 |
| 2024-12-1107:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135212 |
| 2024-11-0616:27 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122377 |
| 2024-11-0616:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122337 |
| 2024-10-2407:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-116853 |
| 2024-09-1316:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-106362 |
| 2024-09-0909:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-104575 |
| 2024-08-1207:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095065 |
| 2024-08-1207:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-095059 |
| 2024-06-1816:06 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-074846 |
| 2024-06-1206:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-072249 |
| 2024-05-1616:09 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000950170-24-061079 |
| 2024-05-0707:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053940 |
| 2024-05-0707:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053931 |
| 2024-04-2616:11 ET | DEF 14A | Proxy statementPeriod 2024-06-14 | 0000950170-24-049126 |
| 2024-04-1016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-043347 |
| 2024-02-1517:22 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-016016 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.